Ask Our Experts June 12, 2024 Exploring a rare form of Alzheimer’s disease affecting younger individuals Alzheimer’s disease, the most common form of dementia in the United States, affects millions of Americans, predominately striking after the age of 60. However, there is a lesser-known rare variant of Alzheimer’s called Posterior Cortical Atrophy (PCA) that makes up about 5% of cases. Read More
Ask Our Experts June 12, 2024 FDA approves the first treatment to reduce the severity of food allergy reactions For the first time, the FDA has approved a treatment to reduce the severity of dangerous allergic reactions due to accidental exposure to food allergens. Here’s what to know about this new tool to help manage food allergies. Read More
Ask Our Experts April 30, 2024 COVID-19 and its impact on high-risk groups There have been a few COVID-19 updates in the news in the last month. It is important for people who are at high-risk of serious illness to be aware of these changes, including adults aged 65 years and older, pregnant people, children aged 5 years and under, and people with weakened immune systems due to medical conditions or immunosuppressive treatments. Read More
Ask Our Experts April 15, 2024 How to talk to kids about cancer At PHM, we advocate for a family-centered approach to care. Alongside our highly skilled advanced practice clinicians, PhD-led research scientists, and expert coordinators, we offer the support of Certified Child Life Specialists in-house. These specialists assist our clients in having difficult conversations with their children following a new cancer diagnosis and prepare them for what emotional or behavioral reactions they can expect. Read More
Ask Our Experts March 7, 2024 Gene editing-based therapies could revolutionize how genetic diseases are treated Patients with the debilitating, inherited blood disorders sickle cell anemia and beta-thalassemia recently received news of a life-changing treatment. The FDA approved Casgevy, a groundbreaking therapy that uses a gene editing tool called CRISPR (pronounced ‘crisper’) to treat these disorders. This is the first ever approval for this innovative type of treatment, which can change the DNA code in a patient’s cells to target the underlying cause of a disease. Read More
Ask Our Experts March 7, 2024 What to know about measles outbreak in the U.S. Measles cases are on the rise globally, despite the availability of a safe and effective vaccine that prevents the infection. In the U.K., where over 400 cases have been detected since October of 2023,1 the alarming surge has been deemed a “national incident.” As a result, the U.S. Centers for Disease Control (CDC) issued a warning for physicians to be on alert for measles cases. Read More